Literature DB >> 10688881

Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.

Y Pommier1, G Kohlhagen, P Pourquier, J M Sayer, H Kroth, D M Jerina.   

Abstract

The catalytic intermediates of DNA topoisomerase I (top1) are cleavage complexes that can relax DNA supercoiling (intramolecular reaction) or mediate recombinations (intermolecular religation). We report here that DNA adducts formed from benzo[a]pyrene bay-region diol epoxides can markedly affect top1 activity. Four oligonucleotide 22-mers of the same sequence were synthesized, each of which contained a stereoisomerically unique benzo[a]pyrene 7, 8-diol 9,10-epoxide adduct at the 2-amino group of a central 2'-deoxyguanosine residue. These four adducts correspond to either cis or trans opening at C-10 of the (+)-(7R, 8S, 9S, 10R)- or (-)-(7S, 8R, 9R, 10S)-7,8-diol 9,10-epoxides. Their solution conformations in duplex DNA (intercalated and minor-groove bound for the cis and trans opened adducts respectively) can be deduced from previous NMR studies. All four adducts completely suppress top1 cleavage activity at the alkylation site and induce the formation of new top1cleavage complexes on both strands of the DNA 3-6 bases away from the alkylation site. The trans opened adduct from the highly carcinogenic (+)-diol epoxide is the most active in inducing top1 cleavage independently of camptothecin, demonstrating that minor groove alkylation can efficiently poison top1. We also found that this isomer of the diol epoxide induces the formation of top1-DNA complexes in mammalian cells, which suggests a possible relationship between induction of top1 cleavage complexes and carcinogenic activity of benzo[a]pyrene diol epoxides.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688881      PMCID: PMC15750          DOI: 10.1073/pnas.040397497

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Simple procedure for isolation of DNA, RNA and protein fractions from cultured animal cells.

Authors:  J L Shaw; J Blanco; G C Mueller
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

Review 2.  Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme.

Authors:  Y Pommier; P Pourquier; Y Fan; D Strumberg
Journal:  Biochim Biophys Acta       Date:  1998-10-01

3.  Minimal DNA duplex requirements for topoisomerase I-mediated cleavage in vitro.

Authors:  J Q Svejstrup; K Christiansen; A H Andersen; K Lund; O Westergaard
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

4.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.

Authors:  B J Bonven; E Gocke; O Westergaard
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

5.  Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.

Authors:  C Jaxel; K W Kohn; Y Pommier
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

6.  The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.

Authors:  S E Porter; J J Champoux
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

7.  Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.

Authors:  M A Bjornsti; P Benedetti; G A Viglianti; J C Wang
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

8.  Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.

Authors:  C Jaxel; G Capranico; D Kerrigan; K W Kohn; Y Pommier
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

9.  Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.

Authors:  Y H Hsiang; L F Liu
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  13 in total

1.  Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.

Authors:  D Strumberg; A A Pilon; M Smith; R Hickey; L Malkas; Y Pommier
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.

Authors:  Y Pommier; G S Laco; G Kohlhagen; J M Sayer; H Kroth; D M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 3.  Mitochondrial DNA damage and its consequences for mitochondrial gene expression.

Authors:  Susan D Cline
Journal:  Biochim Biophys Acta       Date:  2012-06-19

Review 4.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

Review 5.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

6.  Biochemical assays for the discovery of TDP1 inhibitors.

Authors:  Christophe Marchand; Shar-yin N Huang; Thomas S Dexheimer; Wendy A Lea; Bryan T Mott; Adel Chergui; Alena Naumova; Andrew G Stephen; Andrew S Rosenthal; Ganesha Rai; Junko Murai; Rui Gao; David J Maloney; Ajit Jadhav; William L Jorgensen; Anton Simeonov; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2014-07-14       Impact factor: 6.261

7.  Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform.

Authors:  Junko Murai; Christophe Marchand; Sampada A Shahane; Hongmao Sun; Ruili Huang; Yiping Zhang; Adel Chergui; Jiuping Ji; James H Doroshow; Ajit Jadhav; Shunichi Takeda; Menghang Xia; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2014-04-29

8.  Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase.

Authors:  Laurent Debéthune; Glenda Kohlhagen; Anna Grandas; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

9.  Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.

Authors:  Shyamal D Desai; Hui Zhang; Alexandra Rodriguez-Bauman; Jin-Ming Yang; Xiaohua Wu; Murugesan K Gounder; Eric H Rubin; Leroy F Liu
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

10.  Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.

Authors:  Smitha Antony; Paola B Arimondo; Jian-Sheng Sun; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2004-10-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.